phosphorylethanolamine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pettegrew, JW | 1 |
| Kopp, SJ | 1 |
| Minshew, NJ | 1 |
| Glonek, T | 1 |
| Feliksik, JM | 1 |
| Tow, JP | 1 |
| Cohen, MM | 1 |
| Ellison, DW | 1 |
| Beal, MF | 1 |
| Martin, JB | 1 |
2 other studies available for phosphorylethanolamine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: preliminary observations.
Topics: Adult; Aged; Aging; Alzheimer Disease; Animals; Brain; Ethanolamines; Female; Glycerophosphates; Hum | 1987 |
Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease.
Topics: Aged; Alzheimer Disease; Brain; Cerebral Cortex; Chromatography, High Pressure Liquid; Ethanolamine; | 1987 |